Enhancing the drug sensitivity of antibiotics on drug-resistant bacteria via the photothermal effect of FeTGNPs

J Control Release. 2022 Jan:341:51-59. doi: 10.1016/j.jconrel.2021.11.018. Epub 2021 Nov 14.

Abstract

The growing problem of bacterial resistance caused by the abuse of antibiotics is a serious challenge for the world. In order to make the clinically available antibiotics regain their bactericidal effect, our study introduced photothermal therapy (PTT) to assist antibiotics to annihilate drug-resistant bacteria. To achieve the synergistic effect, nanoparticles (FeTGNPs) with an antibiotic core (gatifloxacin complexing with tannins) and a photothermal shell (ferric iron coordinating with tannins) were prepared directly in aqueous solution by a convenient yet efficient one-pot synthesis. The excellent photothermal properties of the shell of FeTGNPs were used to break the mechanism of bacterial resistance, and the sustained-release of gatifloxacin from the core regained the killing effect against drug-resistant bacteria. From the results of antibacterial experiments, with the synergistic effect of APTT and antibiotics, FeTGNPs (400 μg/mL) could effectively kill methicillin-resistant Staphylococcus aureus (sterilizing rate up to 96.5 %) and gatifloxacin-resistant Staphylococcus aureus (sterilizing rate up to 98.7 %) than equivalent antibiotics. Moreover, under slightly acidic microenvironment, such as infection area, gatifloxacin could accelerate its release from the core of FeTGNPs. Therefore, FeTGNPs would be a highly effective antibacterial agent against drug-resistant bacterial infections in the future.

Keywords: Antibiotic abuse; Bacterial resistance; Photothermal therapy; Sensitivity; Synergistic therapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Bacteria
  • Humans
  • Methicillin-Resistant Staphylococcus aureus*
  • Staphylococcal Infections*
  • Staphylococcus aureus

Substances

  • Anti-Bacterial Agents